Found: 22
Select item for more details and to access through your institution.
DTG/3TC Sabit Doz Kombinasyonu (SDK), TAF Bazlı Rejim (TBR) ile Eş Etkilidir: 96-hafta TANGO Alt-grup Analizleri.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2021, p. 93
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 6, p. 975, doi. 10.1093/cid/ciac036
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 8, p. 1920, doi. 10.1093/cid/ciz1243
- By:
- Publication type:
- Article
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M).
- Published in:
- Patient, 2021, v. 14, n. 6, p. 849, doi. 10.1007/s40271-021-00524-0
- By:
- Publication type:
- Article
Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 4, p. 555
- By:
- Publication type:
- Article
Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 11, p. 1607, doi. 10.1093/cid/cit595
- By:
- Publication type:
- Article
Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 12, p. 1810, doi. 10.1093/cid/cit116
- By:
- Publication type:
- Article
Racial/Ethnic Disparities in Engagement in Care and Viral Suppression in a Large Urban HIV Clinic.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Community-Associated Methicillin-Resistant Staphylococcus aureus Colonization in High-Risk Groups of HIV-Infected Patients.
- Published in:
- Clinical Infectious Diseases, 2012, v. 54, n. 9, p. 1296, doi. 10.1093/cid/cis030
- By:
- Publication type:
- Article
Challenges and Successes in Linking HIV-Infected Women to Care in the United States.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. suppl_2, p. S231, doi. 10.1093/cid/ciq047
- By:
- Publication type:
- Article
Paying the Price for Late Starts and Early Stops: Racial and Sex Disparities in HIV-Related Mortality.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 9, p. 1, doi. 10.1093/ofid/ofab439
- By:
- Publication type:
- Article
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
- Published in:
- AIDS Research & Therapy, 2008, v. 5, p. 1, doi. 10.1186/1742-6405-5-5
- By:
- Publication type:
- Article
Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation.
- Published in:
- Journal of Infectious Diseases, 1996, v. 174, n. 3, p. 529, doi. 10.1093/infdis/174.3.529
- By:
- Publication type:
- Article
Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two cases.
- Published in:
- Mycoses, 2010, v. 53, n. 4, p. 356, doi. 10.1111/j.1439-0507.2009.01714.x
- By:
- Publication type:
- Article
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 139, doi. 10.1002/jcph.1306
- By:
- Publication type:
- Article
Optimizing Care for African-American HIV-Positive Patients.
- Published in:
- AIDS Patient Care & STDs, 2003, v. 17, n. 10, p. 527, doi. 10.1089/108729103322494320
- By:
- Publication type:
- Article
Selected Metabolic and Morphologic Complications Associated with Highly Active Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, p. 123, doi. 10.1086/340200
- By:
- Publication type:
- Article
Thymic Size and Lymphocyte Restoration in Patients with Human Immunodeficiency Virus Infection...
- Published in:
- Journal of Infectious Diseases, 2000, v. 181, n. 1, p. 141
- By:
- Publication type:
- Article
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3300
- By:
- Publication type:
- Article